Naropin

ropivacaine hydrochloride · ROPIVACAINE HYDROCHLORIDE 5 mg/mL · Injection, Solution · Epidural; Infiltration; Perineural · Fresenius Kabi USA, LLC

NDC 63323-0286-55 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 30 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Fresenius Kabi AustriaAustria
analysis · manufacture · pack
Fresenius Kabi USA, LLCUnited States
analysis · manufacture
HP Halden Pharma ASNorway
analysis · manufacture · pack

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

Part D specialty tier
Costs ≥ $950/fill
Biologic (BLA)
Injectable / infused
Orphan-drug exclusivity
REMS program

Regulatory

Application: NDA020533
TE code: AP
Approval date: Sep 24, 1996
Patents / exclusivity: 2 patents, 0 exclusivities

Type	Number / code	Expires
patent	7857802	Nov 28, 2026
patent	7857802	Nov 28, 2026

Shortage history

In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)Mar 27, 2018
Other
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)Mar 27, 2018
Other
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)Mar 27, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)Mar 27, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)Mar 27, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)Mar 27, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)Mar 23, 2018
Delay in shipping of the drug
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)Mar 23, 2018
Delay in shipping of the drug
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)Mar 23, 2018
Demand increase for the drug
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)Mar 23, 2018
Other
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)Mar 23, 2018
Other
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)Mar 23, 2018
Other
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)Mar 23, 2018
month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of ropivacaine hydrochloride (Injection, Solution)

Labeler	Strength	First seen	Last seen
Baxter Healthcare Corporation	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Eugia US LLC	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Eugia US LLC	ROPIVACAINE HYDROCHLORIDE 10 mg/mL	Jul 15, 2026	Sep 3, 2026
Eugia US LLC	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE 10 mg/mL	Jul 15, 2026	Sep 3, 2026
Gland Pharma Limited	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Glenmark Pharmaceuticals Inc., USA	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Meitheal Pharmaceuticals Inc.	ROPIVACAINE HYDROCHLORIDE 10 mg/mL	Jul 15, 2026	Sep 3, 2026
Meitheal Pharmaceuticals Inc.	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Meitheal Pharmaceuticals Inc.	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 3, 2026
SOLA Pharmaceuticals, LLC	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 3, 2026
Anthea Pharma Private Limited	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Anthea Pharma Private Limited	ROPIVACAINE HYDROCHLORIDE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
Anthea Pharma Private Limited	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Eugia US LLC	ROPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Fresenius Kabi Usa, Llc	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Sep 2, 2026
Glenmark Pharmaceuticals Inc., USA	ROPIVACAINE HYDROCHLORIDE 10 mg/mL	Jul 15, 2026	Sep 2, 2026
Henry Schein, Inc.	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Hikma Pharmaceuticals USA Inc.	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Meitheal Pharmaceuticals Inc.	ROPIVACAINE HYDROCHLORIDE 7.5 mg/mL	Jul 15, 2026	Sep 2, 2026
Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Sportpharm LLC	ROPIVACAINE HYDROCHLORIDE 5 mg/mL	Jul 15, 2026	Sep 2, 2026
Mylan Institutional LLC	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Aug 31, 2026
Sagent Pharmaceuticals	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Aug 31, 2026
Excella GmbH & Co. KG	ROPIVACAINE HYDROCHLORIDE 1 kg/kg	Jul 15, 2026	Aug 28, 2026
Fresenius Kabi USA, LLC	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Aug 28, 2026
Glenmark Pharmaceuticals Inc., USA	ROPIVACAINE HYDROCHLORIDE 2 mg/mL	Jul 15, 2026	Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Naropin — NDC 63323-0286-55," retrieved September 3, 2026, https://drugdashboards.com/drug/63323028655.

Free to cite with attribution — see how the data is put together.